INDBInternet News Database 2.5 Updated just now · 288 sources Show or hide images Light or dark

Novel Drug May Improve Daily Activities in ET: Phase 3 Trial

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage

Summary

Ulixacaltamide is associated with significantly greater improvement than placebo in all 12 activities of daily living domains assessed in patients with essential tremor in new research.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Novel Drug May Improve Daily Activities in ET: Phase 3 Trial

    Ulixacaltamide is associated with significantly greater improvement than placebo in all 12 activities of daily living domains assessed in patients with essential tremor in new research.

Comments

Comments need JavaScript.